- Supported exchanges /
- PINK /
- ALSE.PINK
Alseres Pharmaceuticals Inc (ALSE PINK) stock market data APIs
Alseres Pharmaceuticals, Inc. focuses on developing diagnostic and therapeutic products primarily for disorders in the central nervous system. Its lead product candidate is Altropane, a molecular imaging agent for the diagnosis of Parkinson's disease and dementia. The company was formerly known as Boston Life Sciences, Inc. and changed its name to Alseres Pharmaceuticals, Inc. in June 2007. Alseres Pharmaceuticals, Inc. was founded in 1972 and is based in Auburndale, Massachusetts.
Alseres Pharmaceuticals Inc Financial Data Overview
0.01 | |
0.01 | |
- | |
0.01 | |
0.01 | |
0.01-0.01 | |
398 K | |
6 127 | |
474 K | |
-52.39 | |
0.215 |
No long-term obligations. The minimum period is one month only. No wait. You get an API key with instructions in a few seconds right after subscription.
Alseres Pharmaceuticals Inc Fundamental Data is available in our Financial Data APIs
- Net Revenue 474 K
- EBITDA -843 188
- Earnings Per Share -0.02
- Income Statements
- Balance Sheets
- Cash flows
of Fundamental API Data
Get Alseres Pharmaceuticals Inc Earnings via APIs
- Latest Release 2014-08-13
- EPS/Forecast NaN
Get Alseres Pharmaceuticals Inc End-of-day Data via APIs
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Our 24/7 support would be happy to assist you via chat or email:
support@eodhistoricaldata.comVisit also: